Thursday, October 6, 2016

Vaccinex Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, to Evaluate the Combination of VX15/2503, and Avelumab in Non-Small Cell Lung Cancer

… Pfizer. 
About Non-Small Cell Lung Cancer
Globally, lung cancer is the most common cause … for people diagnosed with late-stage lung cancer that has spread (metastasized) to … .
3.  American Cancer Society (2016) Lung Cancer (Non-Small Cell) [Detailed Guide]
http …

No comments:

Post a Comment